Catalyst Wire Dossier Catalyst Wire Dossier

Solifenacin succinate suspension

Solifenacin succinate · Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Solifenacin succinate suspension, covering 2017-01-30 to 2017-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug [Phase 3]

See pricing